Shareholders Equity: The sum of preferred and common equity items.
Eton Pharmaceuticals, Inc. (ETON) had Shareholders Equity of $46.59M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$37.59M |
|
$11.58M |
|
$12.18M |
|
$25.41M |
|
$24.80M |
|
$12.79M |
|
$-1.08M |
|
$11.72M |
|
$11.72M |
|
$11.58M |
|
$11.58M |
|
$11.58M |
|
$11.58M |
|
$12.79M |
|
$14.34M |
|
27.64M |
|
32.79M |
|
$0.42 |
|
$0.35 |
|
| Balance Sheet Financials | |
$68.60M |
|
$0.35M |
|
$47.21M |
|
$115.81M |
|
$45.12M |
|
$19.08M |
|
$24.10M |
|
$69.22M |
|
$46.59M |
|
$0.91M |
|
|
Shareholders Equity |
$46.59M |
28.29M |
|
| Cash Flow Statement Financials | |
$14.66M |
|
$-15.07M |
|
$1.31M |
|
$25.94M |
|
$26.84M |
|
$0.90M |
|
$2.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.52 |
|
-- |
|
-- |
|
0.29 |
|
0.60 |
|
67.61% |
|
34.04% |
|
34.04% |
|
-- |
|
31.17% |
|
30.80% |
|
$14.59M |
|
-- |
|
-- |
|
-- |
|
0.32 |
|
1.20 |
|
1.51 |
|
59.59 |
|
24.85% |
|
1276.52% |
|
10.00% |
|
17.63% |
|
$1.65 |
|
$0.45 |
|
$0.45 |
|